Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsBCBSAZ Step Therapy Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield of ArizonaPolicy P247.3

    Step Therapy

    Customize your policy alerts

    Sign up for blue cross blue shield - arizona Policy P247.3 alerts

    Get alerted when Policy P247.3 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Pharmacy coverage criteria for Commercial and Marketplace plans, including medical necessity, prior authorization, step-therapy, documentation, safety, and renewal requirements.

    Policy Summary
    PayerBlue Cross Blue Shield of Arizona
    PolicyStep Therapy
    Policy CodePolicy P247.3
    Change TypeNo material change
    Effective DateN/A
    Last ReviewMay 21, 2026
    Next Review DateN/A
    Key ActionSubmit a signed prior authorization request with chart notes, laboratory results, and supporting clinical documentation when required.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    2Eligible plan types
    4Excluded plan categories
    6 moInitial approval duration
    12 moRenewal duration
    2-stepPreferred therapy sequence

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3
    Exception bases

    Coverage Criteria

    Initial Therapy

    Initial therapy is medically necessary when ALL of the following requirements are met:

    ALL of the following

    • Age is appropriate for the requested Step Therapy Medication.
    • A confirmed diagnosis that is treated by a Step Therapy Medication.
    • The member has failed, has a contraindication to, or is intolerant of drugs listed in the Step Edit Criteria referenced in the Step Therapy Drug List.
    • The requested dosage and duration are consistent with FDA-approved product labeling or established quantity limits.
    • A completed request form is submitted with chart notes, lab results, and supporting clinical documentation.

    Continuation Therapy

    Continuation or renewal therapy is medically necessary when ALL of the following requirements are met:

    ALL of the following

    • There is no evidence of disease progression.
    • There is documented evidence of efficacy, disease stability, and/or improvement.
    • There are no significant unacceptable adverse drug reactions.
    • Adherence to the prescribed therapy regimen has been documented.
    • There are no significant drug-to-drug interactions.
    • There are no contraindications or adverse drug effects that may exclude continued use.

    Initial Step Therapy

    Before coverage of Step Therapy Drug B, the member must have tried preferred Step Therapy Drug A or qualify for an approved exception.

    ALL of the following

    • ONE of the following

      • The member's prescription history confirms receipt of Step Therapy Drug A.
      • Medical record documentation demonstrates failure, intolerance, or a contraindication to Step Therapy Drug A, and BCBSAZ approves a prior authorization exception.
    • If Drug A is not found in the member's prescription history, prior authorization is required before Drug B can be approved.

    Continuation Therapy: Safety and Duration

    Continuation therapy requires ALL of the following ongoing requirements:

    ALL of the following

    • No significant drug-to-drug interactions are present.
    • No contraindications or adverse drug effects exclude continued use.
    • Chart notes and supporting clinical documentation provide evidence of improvement in the given indication.
    • Laboratory values confirm safe use.
    • Approval is limited to 12 months or the end of the plan year, whichever occurs first.

    Off-Label Use Requests

    For a request involving a non-FDA-approved use or an FDA-approved medication used with dosing, frequency, or duration outside the FDA-approved parameters, refer the request to the applicable Pharmacy Coverage Guideline.

    Applicable guideline

    • Off-Label Use of Non-Cancer Medications.
    • Off-Label Use of Cancer Medications.

    This Pharmacy Coverage Guideline applies to Commercial and/or Marketplace plans.

    This Pharmacy Coverage Guideline does not apply to the Federal Employee Program, Medicare Advantage, Medicaid, or members of out-of-state Blue Cross and/or Blue Shield Plans.

    Patient use of samples is not accepted as evidence of an initial course of treatment, justification for continuation of therapy, or evidence of an adequate trial and failure.

    Manufacturer assistance, including coupons and samples, is not considered for continuation of therapy.

    Continuation of therapy is not supported when significant drug-to-drug interactions, contraindications, or adverse drug effects may exclude continued use.

    Initial Therapy Criteria

    Initial Therapy

    Initial therapy requires all of the following age, diagnosis, alternative therapy, safety, and documentation conditions.

    Initial therapy requirements

    • Age requirement: Age is appropriate for the requested Step Therapy Medication.
    • Diagnosis: There is a confirmed diagnosis that is treated by a Step Therapy Medication.
    • Alternative therapy: The member has experienced failure, contraindication, or intolerance to drugs listed in the Step Edit Criteria referenced in the Step Therapy Drug List.
    • Safety:

    Continuation and Renewal Criteria

    Continuation Therapy

    Continuation or renewal therapy requires all of the following clinical response, adherence, safety, and documentation conditions.

    Continuation therapy requirements

    • Clinical response: There is no evidence of disease progression, and documented evidence shows efficacy, disease stability, and/or improvement.
    • Tolerability: There are no significant unacceptable adverse drug reactions.
    • Adherence to the prescribed therapy regimen has been documented.
    • Safety: There are no significant drug-to-drug interactions and no contraindications or adverse drug effects that may exclude continued use.

    Step Therapy Requirements

    StepRequirementCoverage
    1Before coverage of the requested Step Therapy Medication, the member must meet the applicable alternative therapy requirement: failure, contraindication, or intolerance to drugs listed in the Step Edit Criteria referenced in the Step Therapy Drug List.Covered with criteria
    SequenceRequired therapyException
    1Try preferred step therapy drug A before obtaining step therapy drug B. If the automated prescription-history check confirms prior receipt of drug A, drug B may process automatically.A prior authorization exception may be approved when medical record documentation supports failure, intolerance, or contraindication to drug A; if prior use is not found, prior authorization is required.

    Provider Actions and Submission Requirements

    Prior Authorization

    Submit a Signed Prior Authorization Request

    For medications requiring prior authorization, fully complete the applicable request form, obtain the prescribing provider’s signature, and submit it to BCBSAZ Pharmacy Management by fax at (602) 864-3126 or by email to Pharmacyprecert@azblue.com.

    • Review the entire applicable policy and plan requirements before submitting the request.
    Prior Authorization

    Request Authorization for the Nonpreferred Drug

    If the automated prescription-history check does not identify prior use of the preferred drug, request prior authorization before dispensing the nonpreferred drug.

    • A prior authorization is necessary when the member’s history does not show receipt of Drug A before a request for Drug B.

    Policy Background

    This guideline establishes the coverage framework for medications subject to step therapy. Initial approval generally requires an age-appropriate use, a confirmed diagnosis treated by the requested medication, and documented failure, contraindication, or intolerance to the applicable alternative therapies. Requested dosing and duration must follow FDA-approved labeling or established quantity limits, and the required clinical documentation must be submitted.

    For a nonpreferred medication, the member generally must try the preferred product first. If the pharmacy history confirms prior use, the subsequent medication may process automatically; otherwise, prior authorization may be requested with documentation of failure, intolerance, or contraindication to the preferred product. Renewal requires documented clinical benefit, adherence, and continued safe use, including supporting clinical notes and laboratory values.

    Key Definitions

    Step therapy
    DefinitionStep therapy is the practice of beginning a preferred drug for a medical condition before progressing to another therapy.
    Required sequenceThe member must try Step Therapy Drug A before getting Step Therapy Drug B.
    ExceptionDrug B may be obtained without the usual sequence when an approved prior authorization supports bypassing Drug A.
    Automated step therapy process
    Prescription-history checkWhen a prescription for step therapy Drug B is presented, the pharmacy system automatically checks the member's prescription history for prior receipt of Drug A.
    Automatic processingIf the system finds that the member has received Drug A, the prescription for Drug B automatically processes.
    Policy Summary
    PayerBlue Cross Blue Shield of Arizona
    PolicyStep Therapy
    Policy CodePolicy P247.3
    Change TypeNo material change
    Effective DateN/A
    Last ReviewMay 21, 2026
    Next Review DateN/A
    Key ActionSubmit a signed prior authorization request with chart notes, laboratory results, and supporting clinical documentation when required.
    SourceLink
    On This Page
    Coverage CriteriaInitial Therapy CriteriaContinuation and Renewal CriteriaStep Therapy RequirementsProvider Actions and Submission RequirementsPolicy BackgroundKey Definitions
  1. Documentation includes chart notes, supporting clinical documentation with evidence of improvement in the given indication, and laboratory values that confirm safe use.
  2. The requested dosage and duration are consistent with FDA-approved product labeling or set quantity limits.
  3. Documentation: A completed request form, chart notes, laboratory results, and supporting clinical documentation are submitted.

    The prescribing provider must sign the request form.

  4. Initial Step Therapy

    Coverage of step therapy drug B generally follows use of preferred drug A.

    Initial step therapy pathway

    • Automated approval pathway: The pharmacy history identifies prior receipt of preferred drug A.

      Drug B may process automatically.

    • Prior authorization exception pathway: The provider submits medical record documentation of failure, intolerance, or contraindication to drug A, and BCBSAZ approves drug B.
  5. Renewal documentation: Chart notes, supporting clinical documentation with evidence of improvement in the indication, and laboratory values confirming safe use are submitted.
  6. Continuation Therapy

    Continuation therapy is approved when clinical improvement and safe use are documented.

    Continuation criteria: Chart notes and supporting clinical documentation demonstrate evidence of improvement in the indication; laboratory values confirm safe use; and no significant drug-to-drug interactions, contraindications, or adverse drug effects exclude continued use.Approval duration: 12 months or end of plan year
    Documentation Required

    Document Alternative Therapy History

    Document the member’s history with the alternatives listed in the applicable Step Edit Criteria, including failure, contraindication, or intolerance, when requesting coverage based on an alternative-therapy exception.

    • Reference the Step Therapy Drug List and applicable Step Edit Criteria.
    Denial Risk

    Meet Dosing and Quantity Limits

    Ensure the requested dosage and duration are consistent with FDA-approved product labeling or established quantity limits.

    • Requests outside labeled dosing or quantity limits may require additional review or may not be approved.
    Step Therapy

    Complete the Preferred Drug Trial

    Drug A is generally required before Drug B under step therapy. Confirm that the preferred-drug trial requirement has been met or that an approved exception applies.

    • Step therapy begins with the preferred drug before progressing to the nonpreferred therapy.
    Documentation Required

    Include Prior Authorization Documentation

    Submit a completed prior authorization request form with the clinical information needed for review.

    • Chart notes
    • Lab results or laboratory workup
    • Supporting clinical documentation
    • Prescribing provider signature
    Documentation Required

    Document Renewal Eligibility

    For renewal requests, submit evidence that the member has improved on therapy along with documentation supporting continued treatment.

    • Manufacturer coupons, manufacturer assistance, and samples are not evidence of continuation of therapy.
    Documentation Required

    Provide Required Clinical Documentation

    Provide documentation demonstrating clinical benefit and safe ongoing use of the requested therapy.

    • Chart notes
    • Supporting clinical documentation with evidence of improvement for the indication
    • Laboratory values confirming safe use
    Step Therapy

    Document the Step-Therapy Exception

    To bypass step therapy, submit medical-record evidence that the member failed, could not tolerate, or has a contraindication to Drug A.

    • BCBSAZ reviews the submitted documentation before authorizing Drug B.
    Note

    Follow the Off-Label Use Policy

    For use outside FDA-approved guidelines, refer to the appropriate Off-Label Use policy.

    Denial Risk

    Samples Do Not Satisfy Step Requirements

    Do not rely on patient use of samples to establish an initial treatment course, continuation of therapy, or adequate trial and failure.

    • Samples do not satisfy step-therapy requirements.
    Denial Risk

    Exclude Manufacturer Assistance from Renewal Evidence

    Do not use manufacturer assistance as evidence supporting continuation or renewal of therapy.

    • Examples include manufacturer coupons and samples.
    Prior Authorization

    Address Missing Preferred-Therapy History

    When the member’s prescription history does not document receipt of the preferred therapy, submit a prior authorization request for the nonpreferred drug.

    • Drug B will not automatically process unless the system identifies prior Drug A use or the request is approved.
    Denial Risk

    Confirm Safe Continuation

    Before requesting continuation, confirm that the therapy remains safe for the member and document any issues that could prevent continued use.

    • No significant drug-to-drug interactions
    • No contraindications
    • No adverse drug effects that may exclude continued use
    No prior historyIf the system does not find Drug A in the member's prescription history, prior authorization is necessary.
    Prior authorization
    Review processPrior authorization allows providers to submit medical record documentation for review by BCBSAZ.
    Supporting documentationDocumentation must support failure, intolerance, or contraindications that may exist for preferred Drug A.
    Approval outcomeIf BCBSAZ approves the request, authorization for Drug B can be entered into the member's pharmacy record to bypass the preferred product.